Wu Z, Isley N, Boger D
ACS Infect Dis. 2018; 4(10):1468-1474.
PMID: 30067012
PMC: 6200594.
DOI: 10.1021/acsinfecdis.8b00152.
Phillips-Jones M, Harding S
Biophys Rev. 2018; 10(2):347-362.
PMID: 29525835
PMC: 5899746.
DOI: 10.1007/s12551-018-0404-9.
Phillips-Jones M, Lithgo R, Dinu V, Gillis R, Harding J, Adams G
Sci Rep. 2017; 7(1):12697.
PMID: 28983082
PMC: 5629194.
DOI: 10.1038/s41598-017-12620-z.
Shugrue C, Miller S
Chem Rev. 2017; 117(18):11894-11951.
PMID: 28580785
PMC: 5742423.
DOI: 10.1021/acs.chemrev.7b00022.
Phillips-Jones M, Channell G, Kelsall C, Hughes C, Ashcroft A, Patching S
Sci Rep. 2017; 7():46180.
PMID: 28397853
PMC: 5387412.
DOI: 10.1038/srep46180.
Asymmetric catalysis at a distance: catalytic, site-selective phosphorylation of teicoplanin.
Han S, Miller S
J Am Chem Soc. 2013; 135(33):12414-21.
PMID: 23924210
PMC: 3790668.
DOI: 10.1021/ja406067v.
Investigation into the functional impact of the vancomycin C-ring aryl chloride.
Pinchman J, Boger D
Bioorg Med Chem Lett. 2013; 23(17):4817-9.
PMID: 23880541
PMC: 3757926.
DOI: 10.1016/j.bmcl.2013.06.080.
Chemical tailoring of teicoplanin with site-selective reactions.
Pathak T, Miller S
J Am Chem Soc. 2013; 135(22):8415-22.
PMID: 23692563
PMC: 3800266.
DOI: 10.1021/ja4038998.
Probing the role of the vancomycin e-ring aryl chloride: selective divergent synthesis and evaluation of alternatively substituted E-ring analogues.
Pinchman J, Boger D
J Med Chem. 2013; 56(10):4116-24.
PMID: 23617725
PMC: 3667592.
DOI: 10.1021/jm4004494.
Structure of the complex between teicoplanin and a bacterial cell-wall peptide: use of a carrier-protein approach.
Economou N, Zentner I, Lazo E, Jakoncic J, Stojanoff V, Weeks S
Acta Crystallogr D Biol Crystallogr. 2013; 69(Pt 4):520-33.
PMID: 23519660
PMC: 3606034.
DOI: 10.1107/S0907444912050469.
Silver(I)-promoted conversion of thioamides to amidines: divergent synthesis of a key series of vancomycin aglycon residue 4 amidines that clarify binding behavior to model ligands.
Okano A, James R, Pierce J, Xie J, Boger D
J Am Chem Soc. 2012; 134(21):8790-3.
PMID: 22568755
PMC: 3365631.
DOI: 10.1021/ja302808p.
Total synthesis of [Ψ[C(═S)NH]Tpg4]vancomycin aglycon, [Ψ[C(═NH)NH]Tpg4]vancomycin aglycon, and related key compounds: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.
Xie J, Okano A, Pierce J, James R, Stamm S, Crane C
J Am Chem Soc. 2011; 134(2):1284-97.
PMID: 22188323
PMC: 3262083.
DOI: 10.1021/ja209937s.
A redesigned vancomycin engineered for dual D-Ala-D-ala And D-Ala-D-Lac binding exhibits potent antimicrobial activity against vancomycin-resistant bacteria.
Xie J, Pierce J, James R, Okano A, Boger D
J Am Chem Soc. 2011; 133(35):13946-9.
PMID: 21823662
PMC: 3164945.
DOI: 10.1021/ja207142h.
Synthesis and evaluation of selected key methyl ether derivatives of vancomycin aglycon.
Crane C, Pierce J, Leung S, Tirado-Rives J, Jorgensen W, Boger D
J Med Chem. 2010; 53(19):7229-35.
PMID: 20853900
PMC: 2981068.
DOI: 10.1021/jm100946e.
Structure of ristocetin A in complex with a bacterial cell-wall mimetic.
Nahoum V, Spector S, Loll P
Acta Crystallogr D Biol Crystallogr. 2009; 65(Pt 8):832-8.
PMID: 19622867
PMC: 2714720.
DOI: 10.1107/S0907444909018344.
Synthesis and evaluation of vancomycin aglycon analogues that bear modifications in the N-terminal D-leucyl amino acid.
Crane C, Boger D
J Med Chem. 2009; 52(5):1471-6.
PMID: 19209892
PMC: 2765482.
DOI: 10.1021/jm801549b.
Total synthesis and evaluation of [Psi[CH2NH]Tpg4]vancomycin aglycon: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.
Crowley B, Boger D
J Am Chem Soc. 2006; 128(9):2885-92.
PMID: 16506767
PMC: 2586002.
DOI: 10.1021/ja0572912.
Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. sp.
Somma S, Gastaldo L, Corti A
Antimicrob Agents Chemother. 1984; 26(6):917-23.
PMID: 6240963
PMC: 180050.
DOI: 10.1128/AAC.26.6.917.
Transpeptidase activity of Streptomyces D-alanyl-D carboxypeptidases.
Pollock J, Ghuysen J, Linder R, Salton M, Perkins H, Nieto M
Proc Natl Acad Sci U S A. 1972; 69(3):662-6.
PMID: 4501580
PMC: 426530.
DOI: 10.1073/pnas.69.3.662.
Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
Weiss H, Rogers J, Brand H
J Clin Invest. 1973; 52(11):2697-707.
PMID: 4201262
PMC: 302536.
DOI: 10.1172/JCI107464.